Dr. Wanrudee Isaranuwatchai is a Secretary General and Senior Researcher of the Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand. She is also an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada.H

This is a promising time for the advancement of evidence and use of health technology assessment (HTA) in the Philippines. The HTA unit, STEP (Sentro ng Pagsusuri ng Teknolohiyang ngkalusugan), is currently conducting three studies to support national decision-making: 1) the economic evaluatio

As part of the pursuit of universal health coverage (UHC), the Philippine Department of Health (DOH) has been taking concrete steps to institutionalize Health Technology Assessment (HTA), a mechanism that enables the integration of evidence in policy making for health investments, and a fair priorit

In January 2019, the Minister of Health from Chhattisgarh state, India, reached out to International Health Policy Program (IHPP), a semi-autonomous research program in Thailand, to learn about the Thai experience of implementing Universal Health Coverage (UHC). The minister requested to meet with s

( 11- 16 November 2013) Health Intervention and Technology Assessment Program (HITAP) researchers and the program leader, Dr. Yot Teerwattananon, made a scoping visit to Vietnam in November 2013. The purpose of the scoping visit was to evaluate the current status of Health Technology Assessment (HTA

WASHINGTON — A wide-ranging surveillance operation by the Food and Drug Administration against a group of its own scientists used an enemies list of sorts as it secretly captured thousands of e-mails that the disgruntled scientists sent privately to members of Congress, lawyers, labor officials, jou

BackgroundRecently the Saw Swee Hock School of Public Health (SSHSPH) at the National University of Singapore (NUS) held the Leadership Development Programme (LDP) with primary focus on advancing universal health coverage (UHC) through the use of HTA. And Prof Kishore Mahbubani, who is the Senior Ad

How do decision-makers in Thailand decide whether a new or improved vaccine should be added to the Expanded Program on Immunization (EPI)?What is the vaccine prioritization and selection processes in Thailand?How can the product preferences of low and middle-income countries (LMICS) be better commun

Abstract Early health technology assessment (early HTA) is a useful tool in guiding the innovation development process in medical technology development. However, the application of early HTA is sub-optimal amongst research and development (R&D) communities due to several challenges. In this pa

It is vital to have evidence-informed clinical practice guidelines or clinical indications to guide the usage of high-cost drugs in the benefits package under the Indonesian universal health coverage (JKN), managed by BPJS Kesehatan. A transparent and legit mechanism is required to support and mo